It sure is weird @Teddyward .... complaining about the wide use of one drug (Paxlovid) that has actually undertaken human clinical trials for COVID-19 while at the same time chanting for the approval of another (Viraleze) that has no human clinical trial data (yet) ?
Like I have said here repeatedly .... it's always someone else's fault according to some on here - perhaps they should look at where the blame squarely lies JF & Co. as they are the ones running Starpharma and making all of these decisions to or not to run clinical trials etc years ago when they had the chance ?
Covid - Vaccine - Viraleze, page-4
-
- There are more pages in this discussion • 264 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.8¢ | $5.111K | 51.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10162 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 199768 | 2 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |